IJDVL Home  
 

STUDIES
[View FULLTEXT] [Download PDF]  
Year : 2004  |  Volume : 70  |  Issue : 5  |  Page : 288-291

Efficacy of desonide 0.05% cream and lotion in steroid-responsive dermatoses in Indian patients: A post-marketing surveillance study

Dimple A Bhankharia1, Percy H Sanjana2 
1 Mumbai, India
2 Galderma India Pvt. Ltd, Mumbai, India

Correspondence Address:
Percy H Sanjana
Galderma India Pvt. Ltd., 23 Steelmade Industrial Estate, 2nd Floor, Marol Village, Andheri (E), Mumbai - 400 059
India

BACKGROUND: Desonide, a non-halogenated, low-potency topical steroid, is indicated in the treatment of steroid-responsive dermatoses. AIMS: A post-marketing surveillance study was conducted to evaluate the efficacy and safety of DesowenTM (Desonide 0.05%) cream and lotion in Indian patients for the treatment of steroid-responsive dermatoses of mild to moderate severity. METHODS: A 3-week, multicenter, open-label, non-comparative Phase IV trial involving 1789 patients from 229 centers across India was conducted between January and August 2003. RESULTS: Of the 1789 patients, 1483 patients completed the treatment as per protocol. At the end of the therapy, 98.5% of the patients showed an improvement in their dermatitis from baseline. More than half of the patients showed a greater than 75% improvement in their signs and symptoms. No adverse effects were noted in any of the patients. Both the lotion and cream were found to be equally effective. CONCLUSIONS: Desonide 0.05% is a safe and effective low-potency corticosteroid for the treatment of mild to moderate dermatoses in Indian patients. No clinically apparent side-effects were observed in infants less than 1 year of age.


How to cite this article:
Bhankharia DA, Sanjana PH. Efficacy of desonide 0.05% cream and lotion in steroid-responsive dermatoses in Indian patients: A post-marketing surveillance study.Indian J Dermatol Venereol Leprol 2004;70:288-291


How to cite this URL:
Bhankharia DA, Sanjana PH. Efficacy of desonide 0.05% cream and lotion in steroid-responsive dermatoses in Indian patients: A post-marketing surveillance study. Indian J Dermatol Venereol Leprol [serial online] 2004 [cited 2020 Nov 29 ];70:288-291
Available from: https://www.ijdvl.com/article.asp?issn=0378-6323;year=2004;volume=70;issue=5;spage=288;epage=291;aulast=Bhankharia;type=0


 

Sunday, November 29, 2020
 Site Map | Home | Contact Us | Feedback | Copyright and disclaimer